Article Versions Notes

Emelianov EA, Naberezhnaya ER, Logvinov AS, Stepanova VM, Chernov AS, Mokrushina YA, Malabuiok DM, Pershin DE, Malakhova EA, Kulakovskaya EA, et al. Pre-Treatment with Dacarbazine Sensitizes B16 Melanoma to CAR T Cell Therapy in Syngeneic Mouse Model. International Journal of Molecular Sciences. 2026; 27(1):189. https://doi.org/10.3390/ijms27010189

Emelianov, Egor A., Elizaveta R. Naberezhnaya, Andrey S. Logvinov, Valeria M. Stepanova, Aleksandr S. Chernov, Yuliana A. Mokrushina, Diana M. Malabuiok, Dmitry E. Pershin, Ekaterina A. Malakhova, Elena A. Kulakovskaya, and et al. 2026. "Pre-Treatment with Dacarbazine Sensitizes B16 Melanoma to CAR T Cell Therapy in Syngeneic Mouse Model" International Journal of Molecular Sciences 27, no. 1: 189. https://doi.org/10.3390/ijms27010189

Emelianov, E. A., Naberezhnaya, E. R., Logvinov, A. S., Stepanova, V. M., Chernov, A. S., Mokrushina, Y. A., Malabuiok, D. M., Pershin, D. E., Malakhova, E. A., Kulakovskaya, E. A., Prokofeva, T. N., Tatarskiy, V. V., Shramova, E. I., Deyev, S. M., Gabibov, A. G., Kushlinskii, N. E., Rubtsov, Y. P., & Volkov, D. V. (2026). Pre-Treatment with Dacarbazine Sensitizes B16 Melanoma to CAR T Cell Therapy in Syngeneic Mouse Model. International Journal of Molecular Sciences, 27(1), 189. https://doi.org/10.3390/ijms27010189